Status:
COMPLETED
Lymph Drainage in Heart Failure
Lead Sponsor:
Duke University
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to test the safety and efficacy of lymph fluid drainage on heart congestion and shortness of breath symptoms among patients participants with heart failure.
Eligibility Criteria
Inclusion
- Age 18 years or older
- Subjects with informed consent to participate
- NYHA III- IV patients
- Patients with heart failure volume overload
- Planned for elective right heart catheterization
Exclusion
- Active coronary syndrome (type I myocardial infarction)
- Local infection or ongoing systemic infection(s)
- Thrombotic coagulation disorder
- On continuous blood thinners that cannot be discontinued or held
- Allergy or contraindications to the use of iodine-based contrast agents
- Subjects deemed to be high risk for performing a cardiac catheterization by study investigator
Key Trial Info
Start Date :
October 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT05240638
Start Date
October 24 2022
End Date
July 7 2023
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marat Fudim
Durham, North Carolina, United States, 27710-0001